Erratum to: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis (Nature Medicine, (2017), 23, 5, (590-600), 10.1038/nm.4305)

Luigina Romani, Vasilis Oikonomou, Silvia Moretti, Rossana G. Iannitti, Maria Cristina D’Adamo, Valeria R. Villella, Marilena Pariano, Luigi Sforna, Monica Borghi, Marina M. Bellet, Francesca Fallarino, Maria Teresa Pallotta, Giuseppe Servillo, Eleonora Ferrari, Paolo Puccetti, Guido Kroemer, Mauro Pessia, Luigi Maiuri, Allan L. Goldstein, Enrico Garaci

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the version of this article originally published, some labels in Fig. 1f are incorrect. The “β-actin” labels on the second and fourth rows of blots should instead be “β-tubulin”. The error has been corrected in the HTML and PDF versions of this article.

Original languageEnglish
Pages (from-to)1481
Number of pages1
JournalNature Medicine
Volume24
Issue number9
DOIs
Publication statusPublished - Sep 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint

Dive into the research topics of 'Erratum to: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis (Nature Medicine, (2017), 23, 5, (590-600), 10.1038/nm.4305)'. Together they form a unique fingerprint.

Cite this